# ServiceTitan, Inc.: financial statements, quarterly

TTAN · Nasdaq · CIK 1638826 · [Technology](/sectors/technology.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/ttan.md) · [Financials](/companies/ttan/financials.md) · [Filings](/companies/ttan/filings.md) · [Insiders](/companies/ttan/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ttan/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-10-31) | period not labelled (2024-01-31) | period not labelled (2024-04-30) | period not labelled (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [160](/filings/0000950170-25-005456.md) | [162 d](/filings/0001638826-26-000028.md) | [170](/filings/0000950170-25-085509.md) | [193](/filings/0000950170-25-114005.md) | [199](/filings/0001193125-25-312847.md) | [209 d](/filings/0001638826-26-000028.md) | [216](/filings/0001638826-26-000047.md) | [242](/filings/0001638826-26-000094.md) | [249](/filings/0001193125-25-312847.md) | [254 d](/filings/0001638826-26-000028.md) | [269](/filings/0001638826-26-000047.md) | [293](/filings/0001638826-26-000094.md) |
| Cost of revenue | $m | [57.3](/filings/0000950170-25-005456.md) | [61.6 d](/filings/0001638826-26-000028.md) | [64.3](/filings/0000950170-25-085509.md) | [66.2](/filings/0000950170-25-114005.md) | [69.3](/filings/0001193125-25-312847.md) | [71.1 d](/filings/0001638826-26-000028.md) | [67.3](/filings/0001638826-26-000047.md) | [70.8](/filings/0001638826-26-000094.md) | [72.8](/filings/0001193125-25-312847.md) | [76.3 d](/filings/0001638826-26-000028.md) | [75.0](/filings/0001638826-26-000047.md) | [83.7](/filings/0001638826-26-000094.md) |
| Gross profit | $m | [103](/filings/0000950170-25-005456.md) | [100 d](/filings/0001638826-26-000028.md) | [106](/filings/0000950170-25-085509.md) | [127](/filings/0000950170-25-114005.md) | [130](/filings/0001193125-25-312847.md) | [138 d](/filings/0001638826-26-000028.md) | [148](/filings/0001638826-26-000047.md) | [171](/filings/0001638826-26-000094.md) | [176](/filings/0001193125-25-312847.md) | [178 d](/filings/0001638826-26-000028.md) | [194](/filings/0001638826-26-000047.md) | [209](/filings/0001638826-26-000094.md) |
| Research and development | $m | [49.1](/filings/0000950170-25-005456.md) | [54.4 d](/filings/0001638826-26-000028.md) | [58.6](/filings/0000950170-25-085509.md) | [62.4](/filings/0000950170-25-114005.md) | [65.9](/filings/0001193125-25-312847.md) | [76.1 d](/filings/0001638826-26-000028.md) | [69.1](/filings/0001638826-26-000047.md) | [73.1](/filings/0001638826-26-000094.md) | [78.5](/filings/0001193125-25-312847.md) | [81.9 d](/filings/0001638826-26-000028.md) | [88.0](/filings/0001638826-26-000047.md) | [101](/filings/0001638826-26-000094.md) |
| Operating income | $m | [(36.1)](/filings/0000950170-25-005456.md) | [(48.1) d](/filings/0001638826-26-000028.md) | [(53.4)](/filings/0000950170-25-085509.md) | [(32.6)](/filings/0000950170-25-114005.md) | [(44.0)](/filings/0001193125-25-312847.md) | [(99.9) d](/filings/0001638826-26-000028.md) | [(49.5)](/filings/0001638826-26-000047.md) | [(34.8)](/filings/0001638826-26-000094.md) | [(42.2)](/filings/0001193125-25-312847.md) | [(42.7) d](/filings/0001638826-26-000028.md) | [(25.8)](/filings/0001638826-26-000047.md) | [(27.6)](/filings/0001638826-26-000094.md) |
| Interest expense | $m | [4.2](/filings/0000950170-25-005456.md) | [4.2 d](/filings/0001638826-26-000028.md) | [4.1](/filings/0000950170-25-085509.md) | [4.2](/filings/0000950170-25-114005.md) | [4.0](/filings/0001193125-25-312847.md) | [3.2 d](/filings/0001638826-26-000028.md) | [2.0](/filings/0001638826-26-000047.md) | [2.1](/filings/0001638826-26-000094.md) | [2.0](/filings/0001193125-25-312847.md) | [1.1 d](/filings/0001638826-26-000028.md) | [0.2](/filings/0001638826-26-000047.md) | [0.2](/filings/0001638826-26-000094.md) |
| Income tax | $m | [1.0](/filings/0000950170-25-005456.md) | [1.2 d](/filings/0001638826-26-000028.md) | [0.4](/filings/0000950170-25-085509.md) | [0.5](/filings/0000950170-25-114005.md) | [0.4](/filings/0001193125-25-312847.md) | [1.1 d](/filings/0001638826-26-000028.md) | [0.2](/filings/0001638826-26-000047.md) | [0.4](/filings/0001638826-26-000094.md) | [0.6](/filings/0001193125-25-312847.md) | [1.5 d](/filings/0001638826-26-000028.md) | [1.0](/filings/0001638826-26-000047.md) | [1.4](/filings/0001638826-26-000094.md) |
| Net income | $m | [(39.7)](/filings/0000950170-25-005456.md) | [(51.4) d](/filings/0001638826-26-000028.md) | [(56.0)](/filings/0000950170-25-085509.md) | [(35.7)](/filings/0000950170-25-114005.md) | [(46.5)](/filings/0001193125-25-312847.md) | [(101) d](/filings/0001638826-26-000028.md) | [(46.4)](/filings/0001638826-26-000047.md) | [(32.2)](/filings/0001638826-26-000094.md) | [(39.5)](/filings/0001193125-25-312847.md) | [(41.7) d](/filings/0001638826-26-000028.md) | [(22.8)](/filings/0001638826-26-000047.md) | [(24.9)](/filings/0001638826-26-000094.md) |
| Diluted EPS | $ per share | [(1.53)](/filings/0000950170-25-005456.md) | not reported | [(2.02)](/filings/0000950170-25-085509.md) | [(1.43)](/filings/0000950170-25-114005.md) | [(1.74)](/filings/0001193125-25-312847.md) | not reported | [(0.51)](/filings/0001638826-26-000047.md) | [(0.35)](/filings/0001638826-26-000094.md) | [(0.42)](/filings/0001193125-25-312847.md) | not reported | [(0.24)](/filings/0001638826-26-000047.md) | [(0.26)](/filings/0001638826-26-000094.md) |
| Basic EPS | $ per share | [(1.53)](/filings/0000950170-25-005456.md) | not reported | [(2.02)](/filings/0000950170-25-085509.md) | [(1.43)](/filings/0000950170-25-114005.md) | [(1.74)](/filings/0001193125-25-312847.md) | not reported | [(0.51)](/filings/0001638826-26-000047.md) | [(0.35)](/filings/0001638826-26-000094.md) | [(0.42)](/filings/0001193125-25-312847.md) | not reported | [(0.24)](/filings/0001638826-26-000047.md) | [(0.26)](/filings/0001638826-26-000094.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-10-31) | period not labelled (2024-01-31) | period not labelled (2024-04-30) | period not labelled (2024-07-31) | Q3 FY2025 (2024-10-31) | FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [150](/filings/0000950170-25-005456.md) | [147](/filings/0001638826-26-000028.md) | [116](/filings/0000950170-25-085509.md) | [128](/filings/0000950170-25-114005.md) | [134](/filings/0001193125-25-312847.md) | [442](/filings/0001638826-26-000028.md) | [420](/filings/0001638826-26-000047.md) | [471](/filings/0001638826-26-000094.md) | [493](/filings/0001193125-25-312847.md) | [429](/filings/0001638826-26-000094.md) | [422](/filings/0001638826-26-000047.md) | [480](/filings/0001638826-26-000094.md) |
| Current assets | $m | not reported | [249](/filings/0000950170-25-048834.md) | not reported | not reported | [253](/filings/0000950170-25-005456.md) | [573](/filings/0001638826-26-000028.md) | [553](/filings/0000950170-25-085509.md) | [623](/filings/0000950170-25-114005.md) | [644](/filings/0001193125-25-312847.md) | [591](/filings/0001638826-26-000094.md) | [601](/filings/0001638826-26-000047.md) | [670](/filings/0001638826-26-000094.md) |
| Total assets | $m | not reported | [1,518](/filings/0000950170-25-048834.md) | not reported | not reported | [1,468](/filings/0000950170-25-005456.md) | [1,769](/filings/0001638826-26-000028.md) | [1,727](/filings/0000950170-25-085509.md) | [1,784](/filings/0000950170-25-114005.md) | [1,817](/filings/0001193125-25-312847.md) | [1,745](/filings/0001638826-26-000094.md) | [1,747](/filings/0001638826-26-000047.md) | [1,804](/filings/0001638826-26-000094.md) |
| Current liabilities | $m | not reported | [125](/filings/0000950170-25-048834.md) | not reported | not reported | [140](/filings/0000950170-25-005456.md) | [153](/filings/0001638826-26-000028.md) | [115](/filings/0000950170-25-085509.md) | [139](/filings/0000950170-25-114005.md) | [156](/filings/0001193125-25-312847.md) | [169](/filings/0001638826-26-000094.md) | [135](/filings/0001638826-26-000047.md) | [147](/filings/0001638826-26-000094.md) |
| Total liabilities | $m | not reported | [366](/filings/0000950170-25-048834.md) | not reported | not reported | [374](/filings/0000950170-25-005456.md) | [314](/filings/0001638826-26-000028.md) | [273](/filings/0000950170-25-085509.md) | [294](/filings/0000950170-25-114005.md) | [312](/filings/0001193125-25-312847.md) | [220](/filings/0001638826-26-000094.md) | [187](/filings/0001638826-26-000047.md) | [198](/filings/0001638826-26-000094.md) |
| Long-term debt | $m | not reported | [175](/filings/0000950170-25-048834.md) | not reported | not reported | [104](/filings/0000950170-25-005456.md) | [104](/filings/0000950170-25-048834.md) | [104](/filings/0000950170-25-085509.md) | [104](/filings/0000950170-25-114005.md) | [104](/filings/0001193125-25-312847.md) | [0.0](/filings/0001638826-26-000028.md) | not reported | not reported |
| Current portion of debt | $m | not reported | [1.8](/filings/0000950170-25-048834.md) | not reported | not reported | [1.1](/filings/0000950170-25-005456.md) | [1.1](/filings/0001193125-25-312847.md) | [1.1](/filings/0000950170-25-085509.md) | [1.1](/filings/0000950170-25-114005.md) | [1.1](/filings/0001193125-25-312847.md) | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | [1.8](/filings/0000950170-25-048834.md) | not reported | not reported | [1.1](/filings/0000950170-25-005456.md) | [1.1](/filings/0001638826-26-000028.md) | [1.1](/filings/0000950170-25-085509.md) | [1.1](/filings/0000950170-25-114005.md) | [1.1](/filings/0001193125-25-312847.md) | [0.0](/filings/0001638826-26-000028.md) | not reported | not reported |
| Shareholders' equity | $m | [(442)](/filings/0000950170-25-005456.md) | [(478)](/filings/0001638826-26-000028.md) | [(506)](/filings/0000950170-25-114005.md) | [(537)](/filings/0001193125-25-312847.md) | [(577)](/filings/0001193125-25-312847.md) | [1,455](/filings/0001638826-26-000094.md) | [1,454](/filings/0001638826-26-000094.md) | [1,489](/filings/0001638826-26-000094.md) | [1,505](/filings/0001193125-25-312847.md) | [1,525](/filings/0001638826-26-000094.md) | [1,561](/filings/0001638826-26-000094.md) | [1,606](/filings/0001638826-26-000094.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-01-31) | period not labelled (2024-04-30) | period not labelled (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [5.9 d](/filings/0001638826-26-000028.md) | [(19.2)](/filings/0000950170-25-085509.md) | [25.3 d](/filings/0000950170-25-114005.md) | [15.5 d](/filings/0001193125-25-312847.md) | [15.4 d](/filings/0001638826-26-000028.md) | [(14.6)](/filings/0001638826-26-000047.md) | [40.3 d](/filings/0001638826-26-000094.md) | [43.8 d](/filings/0001193125-25-312847.md) | [40.6 d](/filings/0001638826-26-000028.md) | [(1.6)](/filings/0001638826-26-000047.md) | [58.0 d](/filings/0001638826-26-000094.md) |
| Capital expenditure | $m | [5.0 d](/filings/0001638826-26-000028.md) | [0.6](/filings/0000950170-25-085509.md) | [1.2 d](/filings/0000950170-25-114005.md) | [1.0 d](/filings/0001193125-25-312847.md) | [1.0 d](/filings/0001638826-26-000028.md) | [1.3](/filings/0001638826-26-000047.md) | [1.1 d](/filings/0001638826-26-000094.md) | [1.6 d](/filings/0001193125-25-312847.md) | [0.7 d](/filings/0001638826-26-000028.md) | [0.6](/filings/0001638826-26-000047.md) | [1.1 d](/filings/0001638826-26-000094.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2023-10-31) | period not labelled (2024-04-30) | period not labelled (2024-07-31) | Q3 FY2025 (2024-10-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [33.6](/filings/0000950170-25-005456.md) | [34.2](/filings/0000950170-25-085509.md) | [34.8](/filings/0000950170-25-114005.md) | [35.1](/filings/0001193125-25-312847.md) | [90.3](/filings/0001638826-26-000047.md) | [91.7](/filings/0001638826-26-000094.md) | [93.3](/filings/0001193125-25-312847.md) | [95.0](/filings/0001638826-26-000047.md) | [95.9](/filings/0001638826-26-000094.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.